EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtMetaanalyseOpen Access

GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms

Gerardo Uriel Viquez Burboa, Miguel Ángel Rafael Flores Guillén, Vania Sofia Duardo González

Skin Appendage Disorders · 30.06.2026 · 1-9

DOI: 10.1159/000553070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Skin Appendage Disorders, online erschienen am 30.06.2026. Verfasst von Gerardo Uriel Viquez Burboa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hospital General Regional No. 2, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

GLP-1 receptor agonists (GLP-1 RAs) are among the fastest-growing pharmacological classes globally. Alopecia has emerged as a clinically relevant adverse effect signal, yet pooled quantitative estimates of risk by subtype and agent are lacking. The objective of this study was to estimate the pooled risk of alopecia associated with GLP-1 RA use, stratified by subtype, agent, and follow-up duration, and to synthesize mechanistic and management evidence.

Methods

PubMed/MEDLINE, Embase, Cochrane Central, Web of Science, and Scopus were searched from inception to March 31, 2026, with no language restrictions. Studies reporting alopecia outcomes in adult GLP-1 RA users were eligible, including cohort studies, pharmacovigilance disproportionality analyses, and case series (n ≥ 5). Of 1,847 identified records, 17 met eligibility criteria. Random-effects meta-analyses (DerSimonian-Laird) were performed for odds ratios (ORs) and reporting ORs (RORs). The protocol was prospectively registered in PROSPERO (CRD420261335458) and PRISMA 2020 guidelines were followed.

Results

Seventeen studies encompassing 1,091,743 patient-exposures were included. The pooled OR for any non-scarring alopecia was 1.40 (95% CI: 1.33–1.48; I2 = 0%; 3 cohort studies). Significant associations were found for telogen effluvium (aOR, 1.76; 95% CI: 1.34–2.32) and androgenetic alopecia (aOR, 1.64; 95% CI: 1.35–1.99) at 12 months; alopecia areata was not significant (aOR, 1.08; 95% CI: 0.87–1.34). Pharmacovigilance signals were highest for semaglutide (ROR, 2.46; 95% CI: 2.14–2.83) and tirzepatide (ROR, 1.73; 95% CI: 1.43–2.10). Paradoxically, 58% of patients with central centrifugal cicatricial alopecia showed improvement with GLP-1 RA use.

Conclusion

GLP-1 RAs are associated with a significant 40% increased risk of non-scarring alopecia, driven by telogen effluvium and androgenetic alopecia and primarily mediated by weight loss-induced micronutrient deficiency. Semaglutide and tirzepatide carry the highest pharmacovigilance burden. Dermatologists should counsel patients proactively, optimize nutrition, and avoid premature drug discontinuation.

Schlagwörter

Stichwörter der Autor:innen

AlopeciaAndrogenetic alopeciaGLP-1 receptor agonistsMeta-analysisSemaglutideSystematic reviewTelogen effluviumTirzepatide

Autor:innen und Institutionen

  • Hospital General Regional No. 2, Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
  • Departamento de Salud Digital, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

Zitieren

APA

Viquez Burboa, G. U., Flores Guillén, M. Á. R., & Duardo González, V. S. (2026). GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms. Skin Appendage Disorders, 1-9. https://doi.org/10.1159/000553070

Vancouver

Viquez Burboa GU, Flores Guillén MÁR, Duardo González VS. GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms. Skin Appendage Disorders. 2026:1-9. doi:10.1159/000553070

BibTeX
@article{ViquezBurboa2026,
  author = {Viquez Burboa, Gerardo Uriel and Flores Guillén, Miguel Ángel Rafael and Duardo González, Vania Sofia},
  title = {GLP-1 Receptor Agonists and Alopecia: A Systematic Review and Meta-Analysis of Incidence, Risk, Subtypes, and Mechanisms},
  journal = {Skin Appendage Disorders},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000553070}
}
Kostenlos starten →